Bioconjugate recognition molecules to quantum dots as tumor probes

Area of Science:

• Bioconjugation Chemistry
• Nanotechnology
• Biomedical Engineering

Background:

• Quantum dots (QDs) offer unique optical properties for bioimaging.
• Targeted delivery of QDs to specific cells requires functionalization with biomolecules.
• Developing specific and sensitive bioprobes for tumor cell detection is crucial in diagnostics.

Purpose of the Study:

• To covalently conjugate transferrin and anti-CD71 monoclonal antibody to core/shell CdSe/ZnS quantum dots.
• To verify the successful conjugation and retained bioactivity of the functionalized quantum dots.
• To evaluate the specificity of the prepared fluorescent quantum dot bioprobes for tumor cell recognition.

Main Methods:

• Covalent conjugation of biomolecules (transferrin, anti-CD71 antibody) to CdSe/ZnS quantum dots using EDC/Sulfo-NHS chemistry.
• Verification of conjugation and bioactivity using column filtration, SDS-PAGE, absorption/fluorescence spectroscopy, and circular dichroism.
• Assessment of tumor cell recognition specificity using FITC-labeled secondary antibodies to rule out pseudo-positivity.

Main Results:

• Successful covalent conjugation of transferrin and anti-CD71 antibody to quantum dots was achieved.
• The bioactivity of the conjugated macromolecules was confirmed post-conjugation.
• The prepared fluorescent quantum dot bioprobes exhibited high specificity towards tumor cells.

Conclusions:

• Transferrin and anti-CD71 antibody can be effectively conjugated to CdSe/ZnS quantum dots while preserving bioactivity.
• The developed quantum dot bioprobes are highly specific for recognizing tumor cells.
• These bioprobes hold potential for applications in tumor cell detection and diagnostics.